The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) have announced a new US$5 million partnership to accelerate the development of minimally invasive biomarkers for measuring pathologies associated with Parkinson’s and Alzheimer’s diseases. Isobel Coleman, Chief Executive Officer of the Alzheimer’s Drug Discovery… Read More
Pharmaceutical company Astex has entered an exclusive worldwide research agreement with Genentech to identify treatments for breast cancer. The partnership will aim to find small molecule drug candidates with selective inhibitory activity as potential treatments for breast cancer, leveraging Astex’s fragment-based drug discovery programme. Under the terms of… Read More
Memorial Sloan Kettering Cancer Center (MSK) and Quantoom Biosciences have executed a non-exclusive research license and supply agreement to support the development of personalised cancer therapies using Quantoom’s lipid nanoparticle (LNP) formulation technology, Ncapsulate QCX-002. Under the agreement, MSK will use Ncapsulate QCX-002, an LNP delivery chemistry… Read More
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (BIO4), the Republic of Serbia’s flagship biotechnology and life sciences hub, have announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications. Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news this week has emphasised the importance of shared knowledge and expertise to the… Read More
News round-up for 18-22 August by DDW Senior Digital Content Editor Diana Turner. The news this week has emphasised the importance of shared knowledge and expertise to the development of new drugs, whether that is through research collaboration agreements or mergers and acquisitions, with a number of new… Read More
Proteome analysis company Nautilus Biotechnology has announced a partnership with the Allen Institute focused on improving our understanding of neurodegenerative conditions. The organisations will investigate the connection between the tau protein and its occurrence in neurodegenerative conditions such as Alzheimer’s disease. Recent studies suggested that… Read More
Sartorius Stedim Biotech and Sensible Biotechnologies have signed a Memorandum of Understanding (MoU) to jointly advance the industrialisation and scale-up of Sensible’s first-in-class cell-based platform for the design, optimisation, and manufacturing of high-quality mRNA. The collaboration aims to enable clinical-grade production of cell-based mRNA by 2026 and unlock the “next… Read More
The START Center for Cancer Research (START) and OneOncology has announced a strategic partnership to launch early phase clinical trial sites. The rollout includes the Los Angeles Cancer Network (LACN, California), The Center for Cancer and Blood Disorders (CCBD, Texas), and Astera Cancer Care (New Jersey). This arrangement builds on… Read More
Organ-on-a-chip (OOC) company CN Bio has agreed a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea. The agreement is designed to amplify the CN Bio’s presence in major Asian and Pacific markets and broaden access to its predictive human organ models. … Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the… Read More
AI precision medicine company Sonrai Analytics has announced a strategic partnership with AI company Paige designed to improve access to AI capabilities for precision medicine research and development. The partnership will see the integration of Paige’s foundation models with Sonrai’s cloud-based data analytics and bioinformatics platform to make… Read More
News round-up for 14-18 April by DDW Senior Digital Content Editor Diana Spencer. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. Read More
Global health company M42 has announced a strategic investment and partnership with longevity biotech Juvenescence. The partnership will focus on identifying and developing a pipeline of AI-enabled therapeutics to extend healthy lifespan and advance the treatment of life-threatening diseases. The partnership will leverage M42’s expertise in genomics,… Read More
Several new drug discovery collaboration agreements have recently been announced. Entos Pharmaceuticals and Circio Circio Holding and Entos Pharmaceuticals have revealed plans to jointly develop Circio’s optimised circular RNA expression vectors (circVec) using the Entos Fusogenix PLV nucleic acid delivery technology. Under the collaboration, Entos… Read More
Institut Pasteur biotech spin-off Oncovita and Unither Pharmaceuticals have announced plans to develop and produce a new combined prophylactic vaccine for the prevention of infectious diseases in children. This collaboration combines Measovir, Oncovita’s platform designed to develop highly immunogenic vaccines, with Euroject, Unither Pharmaceuticals’ Blow-Fill-Seal (BFS)-based single-dose… Read More
